News
17m
The Observer on MSN‘They’re just not eating as much’: restaurants in the age of weight-loss drugs
As appetites shrink due to medications, so do orders and bills. What does it mean for hospitality if no one is hungry?
A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...
A large study of over 185,000 adults with type 2 diabetes found that GLP-1 receptor agonist use was linked to a slight increase in new diabetic retinopathy cases but fewer severe eye complications, ...
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...
Current weight-loss and diabetes medications, such as GLP-1 drugs, often fail to deliver lasting results and are plagued by ...
The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...
SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher risk of cardiovascular and ...
Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical giant Eli Lilly for allegedly bribing and ...
Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.
Chrissy Metz has opened up about her health journey, sharing her nuanced views on weight loss drugs such as Ozempic.
While clearing up some misconceptions about her health journey, the actress, 44, reflected on the use of medicines like GLP-1 ...
You've likely heard about glucagon-like peptide-1 agonists – usually referred to as GLP-1 medications, and more wildly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results